Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples